RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

NCT05513560 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

460

Enrollment

OTHER

Sponsor class

Conditions

Long COVID
Post COVID Condition
Post Acute Sequelae of COVID-19

Interventions

DRUG: Ibudilast
DRUG: Pentoxifylline
OTHER: Placebo

Sponsor

University Health Network, Toronto